Helius Medical Technologies, Inc. Announces Participation of Neurology Center of New England in its Therapeutic Experience Program
10 janv. 2023 07h05 HE
|
Helius Medical Technologies, Inc.
-- Fifth Center of Excellence added in multi-center, company-sponsored, open label observational interventional trial to evaluate the impact of subjects’ adherence to PoNS® therapy for gait...
Helius Extends its Patient Therapy Access Program (PTAP), Bringing the Benefits of its PoNS® Device to More People with Multiple Sclerosis
05 janv. 2023 07h41 HE
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies (NASDAQ: HSDT) today announced the extension of a program that puts the company’s Portable Neuromodulation Stimulator...
Helius Launches UpScript Telehealth e-Commerce Site, Making it Easier for Americans with Multiple Sclerosis to Access Neurotech that can Improve their Ability to Walk
03 janv. 2023 07h05 HE
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies (NASDAQ: HSDT) launched a new e-commerce site that makes it easier for Americans experiencing issues with their gait to...
Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
30 déc. 2022 16h05 HE
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Dec. 30, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies, Inc. Reports Third Quarter 2022 Financial Results
14 nov. 2022 06h30 HE
|
Helius Medical Technologies, Inc.
-- Total Q3 revenue up 80% over prior year ---- Cash on hand expected to fund operations through 2023 ---- Company to host call at 8:30am today -- NEWTOWN, Pa., Nov. 14, 2022 (GLOBE NEWSWIRE) --...
Helius Medical Technologies, Inc. Announces Participation of Dr. Prue Plummer and MGH Institute of Health Professions to its Therapeutic Experience Program
09 nov. 2022 07h05 HE
|
Helius Medical Technologies, Inc.
-- Fourth Center of Excellence added in multi-center, company-sponsored, open label observational interventional trial to evaluate impact of subjects’ adherence to PoNS® therapy for gait improvement...
Helius Medical Technologies, Inc. Announces Participation of Oregon Health & Science University in its Therapeutic Experience Program
08 nov. 2022 07h05 HE
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the...
Helius to Showcase Innovative PoNS Device at ACRM’s 2022 Conference – Demonstrating the Power of Neuromodulation to Help People with MS Improve their Gait
03 nov. 2022 07h05 HE
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies (NASDAQ: HSDT) will showcase its innovative new Portable Neuromodulation Stimulator (PoNS®) at the 99th annual American...
Helius Medical Technologies, Inc. to Release Third Quarter 2022 Financial Results on November 14, 2022
01 nov. 2022 07h05 HE
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Salutes Physical Therapists for Their Role in Helping People with MS Improve Their Gait
13 oct. 2022 07h05 HE
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Oct. 13, 2022 (GLOBE NEWSWIRE) -- National Physical Therapy Month (NPTM) comes every October, but this one is particularly meaningful to Helius Medical Technologies (NASDAQ: HSDT):...